ネクセラファーマの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/12/23 | 2,013 | 2,059 | 1,977 | 2,025 | -5 | -0.2% | 1,611,600 |
2021/12/22 | 1,965 | 2,037 | 1,936 | 2,030 | +62 | +3.2% | 1,679,100 |
2021/12/21 | 1,916 | 1,970 | 1,872 | 1,968 | +87 | +4.6% | 2,191,500 |
2021/12/20 | 1,847 | 1,941 | 1,823 | 1,881 | +26 | +1.4% | 2,309,900 |
2021/12/17 | 1,885 | 1,909 | 1,838 | 1,855 | -12 | -0.6% | 1,636,700 |
2021/12/16 | 1,918 | 1,919 | 1,860 | 1,867 | -13 | -0.7% | 1,366,700 |
2021/12/15 | 1,888 | 1,891 | 1,838 | 1,880 | -28 | -1.5% | 1,409,900 |
2021/12/14 | 1,921 | 1,955 | 1,888 | 1,908 | -7 | -0.4% | 1,315,100 |
2021/12/13 | 1,970 | 1,989 | 1,897 | 1,915 | -40 | -2% | 1,749,900 |
2021/12/10 | 2,009 | 2,018 | 1,938 | 1,955 | -58 | -2.9% | 1,768,500 |
2021/12/09 | 1,998 | 2,062 | 1,985 | 2,013 | -17 | -0.8% | 1,583,900 |
2021/12/08 | 2,040 | 2,115 | 2,018 | 2,030 | +22 | +1.1% | 3,241,500 |
2021/12/07 | 2,021 | 2,031 | 1,978 | 2,008 | +8 | +0.4% | 1,606,900 |
2021/12/06 | 2,051 | 2,054 | 1,965 | 2,000 | -63 | -3.1% | 1,658,300 |
2021/12/03 | 2,004 | 2,078 | 1,963 | 2,063 | +73 | +3.7% | 2,710,400 |
2021/12/02 | 2,076 | 2,093 | 1,965 | 1,990 | -136 | -6.4% | 3,556,900 |
2021/12/01 | 2,148 | 2,173 | 2,020 | 2,126 | +13 | +0.6% | 2,660,900 |
2021/11/30 | 2,142 | 2,212 | 2,105 | 2,113 | +3 | +0.1% | 3,753,400 |
2021/11/29 | 2,200 | 2,245 | 2,065 | 2,110 | -122 | -5.5% | 5,075,600 |
2021/11/26 | 2,286 | 2,317 | 2,105 | 2,232 | +32 | +1.5% | 9,602,900 |
2021/11/25 | 2,300 | 2,418 | 2,158 | 2,200 | +77 | +3.6% | 22,453,500 |
2021/11/24 | 2,123 | 2,123 | 2,123 | 2,123 | +400 | +23.2% | 176,800 |
2021/11/22 | 1,707 | 1,724 | 1,680 | 1,723 | -2 | -0.1% | 450,600 |
2021/11/19 | 1,719 | 1,733 | 1,708 | 1,725 | +20 | +1.2% | 427,800 |
2021/11/18 | 1,721 | 1,738 | 1,700 | 1,705 | +3 | +0.2% | 576,200 |
2021/11/17 | 1,760 | 1,762 | 1,700 | 1,702 | -61 | -3.5% | 778,500 |
2021/11/16 | 1,741 | 1,811 | 1,741 | 1,763 | +23 | +1.3% | 657,300 |
2021/11/15 | 1,681 | 1,742 | 1,588 | 1,740 | -61 | -3.4% | 1,740,000 |
2021/11/12 | 1,800 | 1,838 | 1,746 | 1,801 | +103 | +6.1% | 1,152,700 |
2021/11/11 | 1,744 | 1,750 | 1,698 | 1,698 | -79 | -4.4% | 540,800 |
2021/11/10 | 1,754 | 1,781 | 1,752 | 1,777 | +18 | +1% | 226,800 |
2021/11/09 | 1,756 | 1,785 | 1,741 | 1,759 | +14 | +0.8% | 443,200 |
2021/11/08 | 1,760 | 1,783 | 1,745 | 1,745 | -22 | -1.2% | 399,700 |
2021/11/05 | 1,790 | 1,790 | 1,751 | 1,767 | -22 | -1.2% | 473,700 |
2021/11/04 | 1,830 | 1,839 | 1,787 | 1,789 | -21 | -1.2% | 399,800 |
2021/11/02 | 1,833 | 1,833 | 1,806 | 1,810 | -12 | -0.7% | 195,300 |
2021/11/01 | 1,830 | 1,840 | 1,804 | 1,822 | +5 | +0.3% | 293,600 |
2021/10/29 | 1,841 | 1,848 | 1,803 | 1,817 | -1 | -0.1% | 249,200 |
2021/10/28 | 1,835 | 1,841 | 1,808 | 1,818 | -25 | -1.4% | 326,900 |
2021/10/27 | 1,880 | 1,881 | 1,830 | 1,843 | -47 | -2.5% | 389,700 |
2021/10/26 | 1,885 | 1,904 | 1,870 | 1,890 | +32 | +1.7% | 277,600 |
2021/10/25 | 1,857 | 1,872 | 1,835 | 1,858 | -19 | -1% | 296,100 |
2021/10/22 | 1,876 | 1,894 | 1,865 | 1,877 | +3 | +0.2% | 270,300 |
2021/10/21 | 1,910 | 1,914 | 1,865 | 1,874 | -44 | -2.3% | 423,100 |
2021/10/20 | 1,930 | 1,948 | 1,906 | 1,918 | +8 | +0.4% | 354,300 |
2021/10/19 | 1,911 | 1,921 | 1,886 | 1,910 | +14 | +0.7% | 240,100 |
2021/10/18 | 1,949 | 1,953 | 1,889 | 1,896 | -48 | -2.5% | 428,100 |
2021/10/15 | 1,956 | 1,956 | 1,914 | 1,944 | +9 | +0.5% | 241,600 |
2021/10/14 | 1,941 | 1,953 | 1,923 | 1,935 | +9 | +0.5% | 295,900 |
2021/10/13 | 1,939 | 1,955 | 1,922 | 1,926 | -18 | -0.9% | 273,300 |
851~
900
件表示中 / 5112件
類似銘柄と比較する
現在ご覧いただいている「ネクセラファーマ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ネクセラファーマ | 90,000円 | +20.3% | - | 0.00% | 159.57倍 | 1.19倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
ハートシード | 366,500円 | +174.2% | - | 0.00% | - | 11.00倍 |
|
慶応大学発ベンチャー。iPS細胞を使い独自の心筋再生用心筋球で重症心不全治療を目指す |
栄研化 | 212,900円 | +4.1% | -3.1% | 2.72% | 18.54倍 | 1.62倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
JCRファーマ | 54,800円 | +14.3% | - | 3.65% | 22.26倍 | 1.42倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
あすかHD | 232,900円 | +16.9% | +33.2% | 2.36% | 12.70倍 | 1.01倍 |
|
武田と親密。婦人科領域に強い。先発品比率引き上げに注力。21年春にあすか製薬が持株会社化 |
市場注目の銘柄
チャート関連のコラム